NCT03738228 2025-11-12Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical CancerNational Cancer Institute (NCI)Phase 1 Completed40 enrolled 17 charts
NCT03073525 2023-04-05A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological CancersGradalis, Inc.Phase 2 Completed25 enrolled 15 charts
NCT02921269 2023-02-21Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical CancerNational Cancer Institute (NCI)Phase 2 Completed11 enrolled 11 charts